In the early stage of tumor development, TANs upregulate the expression of costimulatory molecules OX-40L and 4-1BBL to enhance the T cell immune response and increase the cytotoxicity of CD4+ T cells and CD8+ T cells, to exhibit “tumor inhibition” functions (114, 115). This evidence concerns the gene CD8A and neoplasm.